Strategic Growth Target health systems and hospitals seeking enhanced medication reconciliation at point of care; position ActualMeds as a scalable solution that integrates EHR, HIEs, and claims data to reduce hospitalizations and readmissions, aligning with value-based care initiatives.

Clinical Leadership Engage with the new CEO and clinical leadership to drive adoption; emphasize CRO/CCO level sponsorship and physician/pharmacist involvement through Pharmacist On Demand Services (PODS) to accelerate implementation across care transitions.

Partnerships & Data Leverage existing partnerships and AI-driven reconciliation capabilities with Particle Health to differentiate in care transitions; propose co-marketing or integration discussions with health information exchanges and data vendors to expand reach.

Evidence & ROI Highlight ROI potential from reduced readmissions and optimized medication histories; reference NIH-backed findings and clinical validation to strengthen business cases for payers and hospital networks.

Expansion Signals Capitalize on recent leadership hires and promotional activity as signals of strategic expansion; pursue opportunities in mid- to large-sized health systems and care networks that require scalable reconciliation and risk identification at the point of care.